UNSPSC 51283919: Sulfamethoxazole

This classification denotes a sulfonamide anti-infective agent with the molecular formula C10H11N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JE42381TNV, chemically known as 4-amino-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide but generally known as sulfamethoxazole, which bears US NIH Compound Identifier 5329. European Medicines Agency schedules Sulfamethoxazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10711MIG. The term SULFAMETHOXAZOLE is an International Non-Proprietary Name.

UNSPSC 51283919 Sulfamethoxazole is a Commodity code that captures individual pharmaceutical products procured by state and local health agencies, though recent opportunities show that state and local governments use this code designation inconsistently — the four recorded opportunities span naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, emergency medical supplies, and generic multi-source pharmaceuticals and OTC products. When properly aligned with the code's intent, sulfamethoxazole and similar generic antibiotics are purchased as line items within larger medical supply contracts, emergency response inventories, and pharmaceutical benefit programs. State health departments (Texas HHS Commission), county health systems (Seminole County, Florida), municipal fire and rescue services (City of Tampa), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance) are the primary issuing bodies, with state-level cooperative vehicles and county health departments appearing most frequently in recent activity.

Activity is concentrated in Florida, Minnesota, and Texas, with secondary representation in states participating in the Minnesota cooperative purchasing vehicle. Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems (IFB60459723LAS, due July 26, 2023), the Texas HHS Commission's RFI on direct-to-manufacturer prescriptions (HHS0017013, posted April 3, 2026), the City of Tampa's IFB for medical and first aid supplies for the Fire Department Rescue Division (26P00145, posted March 25, 2026, due March 13, 2026, estimated contract value $700,000.00), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026). The Tampa bid explicitly designates the contract as a sheltered market opportunity for certified Small Local Business Enterprises with a 5% bid discount. Pharmaceutical and medical supply procurement under this code typically runs on one- to two-year terms with renewal options, requires FDA compliance and cGMP certification, and routes through established wholesalers or direct manufacturer relationships.